Watson launches generic contraceptive in midst of Yaz controversy
This article was originally published in Scrip
Executive Summary
Watson Pharmaceuticals has launched its generic version of Bayer HealthCare's Yaz (3 mg drospirenone/0.02 mg ethinyl estradiol) and has already started shipping its oral contraceptive pill, dubbed Vestura.